ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Influence of Pacifiers on Breastfeeding Duration

This study is currently recruiting participants.
Verified by Fundacion para la Salud Materno Infantil, April 2007

Sponsored by: Fundacion para la Salud Materno Infantil
Information provided by: Fundacion para la Salud Materno Infantil
ClinicalTrials.gov Identifier: NCT00306956
  Purpose

The purpose of this study is to determine if the introduction of pacifier use to infants at 2 weeks of age, once breast feedings are well established, will affect the incidence and duration of successful breastfeedings.


Condition Intervention Phase
Sudden Infant Death
Device: pacifier
Phase III

MedlinePlus related topics:   Breast Feeding    Sudden Infant Death Syndrome   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Other, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study
Official Title:   Influence of Pacifiers on Breastfeeding Duration: a Multicentre, Randomised Controlled Trial

Further study details as provided by Fundacion para la Salud Materno Infantil:

Primary Outcome Measures:
  • The prevalence of exclusive breastfeeding for three month old infants between groups randomised to pacifier and no pacifier exposure. Pacifier introduction is delayed until 15 days to ensure that breastfeeding is firmly established.

Secondary Outcome Measures:
  • To evaluate the effects of the pacifier's introduction when breastfeeding is firmly established at 15 days on the duration of breastfeeding
  • To evaluate the median breastfeeding duration in months in relation to the frequency of pacifier use
  • To test whether pacifier use is causally related with muguet, otitis and sore nipples

Estimated Enrollment:   1300
Study Start Date:   March 2006

Detailed Description:

The incidence of Sudden infant death syndrome in developing countries is comparable with that of developed countries. Two important risk factors with implications for prevention are prone sleeping position and the association with smoke. Also, breastfeeding has been reported to be protective against SIDS.

In accordance with WHO/UNICEF recommendations, lactation consultants and other health professionals within “Baby-Friendly” institutions typically discourage the use of pacifiers in breastfed infants. The recent American Academy of Pediatrics policy statement, however, recommends pacifier use, during periods of sleeps as a potential method to reduce the risk of SIDS. Previous observational studies had been unanimous in reporting an approximate doubling of the risk of early weaning with daily pacifier use. However, randomized controlled trials in developed countries, have not shown that giving pacifiers results in shorter breastfeeding duration, except when pacifiers are given in the first 5 days. It has therefore been seen that practically every author of a major study on the association between breastfeeding and pacifier use has proposed that the question can only be fully and completely answered by randomized studies. To date there are no large randomized studies evaluating the influence of pacifier use on breastfeeding duration.

Our Primary outcome is to compare the prevalence of exclusive breastfeeding at three months in infants between groups randomised to pacifier and no pacifier exposure once breastfeedings have been fully established.

Second outcome: to evaluate the effects of the pacifier's introduction when breastfeeding is firmly established at 15 days on the duration of breastfeeding.

Recruitment to the trial will take place in several public and private hospitals.

Those mothers who do not show a strong preference in regards to the introduction of the pacifier, will be randomised during the postpartum visit at 2 weeks (if well established breastfeeding is present) on two arms:

  1. No pacifier,
  2. Pacifier introduced at 15 days.

Structured telephone interviews will be conducted at 1, 2, 3, 4, 5, and 6 months and every 60 days thereafter until the breastfeeding has ended to record breastfeeding duration and type (exclusive or not) and pacifier use.

  Eligibility
Ages Eligible for Study:   up to 18 Days
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Criteria

Inclusion Criteria:

The following patients will be invited to participate before hospital discharge:

  • Women who agree not to introduce the pacifier before 2 weeks
  • Intention to exclusively breastfeed their infants for at least 3 months
  • Breastfeeding exclusively at discharge
  • Delivered a healthy singleton newborn
  • 37 completed weeks and at least a 2.5 kg birth weight
  • Possibility of contact by telephone
  • Patients will be randomized at age 15 days if:

    • They are exclusively breastfeeding
    • They have no existing breastfeeding problems
    • Babies use no pacifiers.
    • Breastfeeding is well established
    • No maternal risk factors for lactation problems

Exclusion Criteria:

  • Extremely or persistently sore nipples
  • Presence of mastitis or abscess formation.
  • Medical situations contraindicating breastfeeding
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00306956

Contacts
Contact: Alejandro G Jenik, M.D.     5411-4799-5747     alejandro.jenik@hospitalitaliano.org.ar    
Contact: Adriana N Gorenstein, M.D.     5411-4127-5534     adrigor@fibertel.com.ar    

Locations
Argentina
Hospital Italiano de Buenos Aires     Recruiting
      Buenos Aires, Argentina, 1181ACH
      Principal Investigator: Alejandro Jenik, M.D.            
      Sub-Investigator: Noemi Jacobi, M.D.            
Sanatorio de la Trinidad     Recruiting
      Buenos Aires, Argentina, 1425
      Contact: Nestor Vain, M.D.     54-11-4127-5534     nvain@trinidad.com.ar    
      Contact: Adriana Gorenstein, M.D.     4127-5535     adrigor@fibertel.com.ar    
      Principal Investigator: Adriana Gorenstein, M.D.            
      Sub-Investigator: Norma Rossato, M.D.            
      Sub-Investigator: Nestor Vain, M.D.            
Argentina, Buenos Aires
Hospital Diego Paroissien     Recruiting
      Isidro Casanova, Buenos Aires, Argentina, 1765
      Contact: Edgardo Szyld, M.D.     54-11-4486-8712     eszyld@fibertel.com.ar    
      Contact: Noemi Lopez, M.D.     54-11-4486-8712     neoparoissien@speedy.com.ar    
      Principal Investigator: Edgardo Szyld, M.D.            
      Sub-Investigator: Noemi López, M.D.            
      Sub-Investigator: Diana Lujan, M.D.            
Hospital Privado del Sur     Recruiting
      Bahia Blanca, Buenos Aires, Argentina, 8000
      Contact: Maria del Carmen Covas, M.D.     54-291-4550270     neonatologia@hps.com.ar    
      Contact: Silvia Ventura, M.D.     54-291-4550270     neonatologia@hps.com.ar    
      Principal Investigator: Maria Del Carmen Covas, M.D.            
      Sub-Investigator: Silvia Ventura, M.D.            
Hospital Municipal Materno Infantil de San Isidro "Dr. Carlos Gianantonio"     Recruiting
      San Isidro, Buenos Aires, Argentina
      Contact: Regina Valverde, MD     5411-45424045     rvalverde@fibertel.com.ar    
      Principal Investigator: Maria del Carmen Degregori, MD            
      Sub-Investigator: Silvia Russo, MD            
      Sub-Investigator: Regina Valverde, MD            

Sponsors and Collaborators
Fundacion para la Salud Materno Infantil

Investigators
Principal Investigator:     Alejandro Jenik, M.D.     Jefe de Recién Nacido Normal, Hospital Italiano, Buenos Aires    
  More Information

Study ID Numbers:   FUNDASAMIN101
First Received:   March 23, 2006
Last Updated:   May 24, 2007
ClinicalTrials.gov Identifier:   NCT00306956
Health Authority:   Argentina: Administracion Nacional de Medicamentos, Alimentos y Tecnologia Medica

Keywords provided by Fundacion para la Salud Materno Infantil:
Infant  
Newborn  
pacifier  
dummies  
breastfeeding
Sudden Infant Death
SIDS
Pacifiers

Study placed in the following topic categories:
Sudden Infant Death
Death
Death, Sudden
Sudden infant death syndrome

Additional relevant MeSH terms:
Pathologic Processes

ClinicalTrials.gov processed this record on September 05, 2008




Links to all studies - primarily for crawlers